Global Financial Private Client, LLC Alkermes Plc. Call Options Transaction History
Global Financial Private Client, LLC
- $262 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
378Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$802 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$509 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$338 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$243 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$208 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...